Santa Cruz Biotechnology supplies a comprehensive collection of PHPT monoclonal antibodies for studying parathyroid hormone-related peptide (PTHrP) in multiple research applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Parathyroid hormone-related peptide plays a crucial role in regulating calcium homeostasis and bone metabolism. PTHrP is actively involved in various physiological processes, including cell proliferation and differentiation, making it a significant focus in cancer research and bone disease studies. Understanding PTHrP function is essential for developing therapeutic strategies for conditions such as hypercalcemia and certain malignancies. Researchers worldwide utilize PTHrP monoclonal antibodies to explore cellular signaling pathways and molecular mechanisms. PHPT monoclonal antibodies enable detailed investigation of protein expression patterns and interactions in different tissue types. Advanced research techniques incorporating PTHrP monoclonal antibodies help identify potential therapeutic targets and biomarkers. Santa Cruz Biotechnology monoclonal antibodies support the scientific community by facilitating breakthrough discoveries in PTHrP research and advancing our understanding of disease mechanisms.